Fensuccimide [DCIT]
Fensuccimide [DCIT] Brand names, Fensuccimide [DCIT] Analogs
- (+/-)-N-Methyl-2-phenylsuccinimide
- 1-Methyl-3-Phenylsuccinimide
- Epimid
- Fenosuccimide
- Fensuccimide [DCIT]
- Fensuximida [INN-Spanish]
- Lifene
- Methylphenylsuccinimide
- Milontin
- Milontin (TN)
- Milonton
- Mirontin
- Mirotin;7 Phenosuccimide
- N-Methyl-2-phenylsuccinimide
- N-Methyl-alpha-phenolsuccinimide
- N-Methyl-alpha-phenylsuccinimide
- Phensuximid
- Phensuximide (USP)
- Phensuximide [BAN:INN]
- Phensuximidum [INN-Latin]
- Phenylsuximide
- Succinimide, N-methyl-2-phenyl-
- Succitimal
Fensuccimide [DCIT] Brand Names Mixture
- No information avaliable
Fensuccimide [DCIT] Chemical_Formula
C11H11NO2
Fensuccimide [DCIT] RX_link
No information avaliable
Fensuccimide [DCIT] fda sheet
Fensuccimide [DCIT] msds (material safety sheet)
Fensuccimide [DCIT] Synthesis Reference
No information avaliable
Fensuccimide [DCIT] Molecular Weight
189.211 g/mol
Fensuccimide [DCIT] Melting Point
72 oC
Fensuccimide [DCIT] H2O Solubility
7020 mg/L
Fensuccimide [DCIT] State
Solid
Fensuccimide [DCIT] LogP
1.079
Fensuccimide [DCIT] Dosage Forms
Capsules
Fensuccimide [DCIT] Indication
For the treatment of epilepsy
Fensuccimide [DCIT] Pharmacology
Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.
Fensuccimide [DCIT] Absorption
Rapid and complete
Fensuccimide [DCIT] side effects and Toxicity
No information avaliable
Fensuccimide [DCIT] Patient Information
No information avaliable
Fensuccimide [DCIT] Organisms Affected
Humans and other mammals
![Fensuccimide_[DCIT]](/images/rx/APRD00496.gif)
